Comment
Author: Admin | 2025-04-28
Effect of simvastatin on the course of age-related macular degeneration. PloS ONE. 2013;8:e83759.55. Tan JS, Mitchell P, Rochtchina E, Wang JJ. Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study. Am J Ophthalmol. 2007;143:685-7.56. Klein R, Klein BE, Tomany SC, et al. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol. 2003;121:1151-5.57. van Leeuwen R, Tomany SC, Wang JJ, et al. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmol. 2004;111:1169-75.58. Vavvas DG, Daniels AB, Kapsala ZG, et al. Regression of some high-risk features of age-related macular degeneration (AMD) in patients receiving intensive statin treatment. EBioMedicine. 2016;5:198-203.59. Ma L, Wang Y, Du J, et al. The association between statin use and risk of age-related macular degeneration. Sci Rep. 2015;5:18280.60. Maguire MG, Ying GS, McCannel CA, et al. Statin use and the incidence of advanced age-related macular degeneration in the complications of age-related macular degeneration prevention trial. Ophthalmol. 2009;116:2381-2385.61. Gehlbach P, Li T, Hatef E. Statins for age-related macular degeneration. Cochrane Database Syst Rev. 2016;Cd006927.62. Roizenblatt M, Naranjit N, Maia M, Gehlbach PL. The question of a role for statins in age-related macular degeneration. Int J Mol Sci. 2018;19:368863. Miller JW, Bagheri S, Vavvas DG. Advances in age-related macular degeneration understanding and therapy. US Ophthalmic Rev. 2017;10:119-130.64. Rajeshuni N, Ludwig CA, Moshfeghi DM. The effect of statin exposure on choroidal neovascularization in nonexudative age-related macular degeneration patients. Eye. 2019;33:163-165.65. Rehak M,
Add Comment